Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Roivant Sciences Ltd (NQ: ROIV ) 11.89 +0.12 (+1.06%) Streaming Delayed Price Updated: 10:19 AM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Roivant Sciences Ltd < Previous 1 2 3 4 5 6 7 Next > Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases December 01, 2022 From Roivant Sciences Via GlobeNewswire Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90% November 15, 2022 Rosenblatt raised the price target on Pinterest, Inc. (NYSE: PINS) from $21 to $23. Rosenblatt analyst Barton Crockett maintained a Neutral rating on the stock. Pinterest shares rose 2% to $24.91 in... Via Benzinga Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94% November 15, 2022 Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday. Via Benzinga Roivant Sciences Reports Financial Results for the Second Quarter Ended September 30, 2022 and Provides Business Update November 14, 2022 From Roivant Sciences Via GlobeNewswire Analyst Ratings for Roivant Sciences June 29, 2022 Within the last quarter, Roivant Sciences (NASDAQ:ROIV) has observed the following analyst ratings: Via Benzinga Roivant, Pfizer Unveil Latest Spinout Focused On Autoimmune Diseases June 28, 2022 Via Benzinga Earnings Scheduled For November 14, 2022 November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday May 11, 2022 On Wednesday, 807 companies reached new 52-week lows. Via Benzinga Affivant to Present Data on AFVT-2101 at 37th Annual Meeting of SITC November 10, 2022 From Roivant Sciences Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 08, 2022 Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. Via Benzinga Roivant Sciences Announces Pricing of Primary and Secondary Public Equity Offering November 08, 2022 From Roivant Sciences Via GlobeNewswire Roivant Sciences Announces Proposed Public Equity Offering November 07, 2022 From Roivant Sciences Via GlobeNewswire Roivant Sciences to Report Financial Results for the Second Quarter Ended September 30, 2022 on Monday, November 14, 2022 and Present at Upcoming Conferences October 18, 2022 From Roivant Sciences Via GlobeNewswire Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday October 07, 2022 U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session. Via Benzinga Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday October 06, 2022 Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday. Via Benzinga Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say September 29, 2022 Via Benzinga Expert Ratings for Roivant Sciences August 16, 2022 Over the past 3 months, 4 analysts have published their opinion on Roivant Sciences (NASDAQ:ROIV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... Via Benzinga JELD-WEN, Royal Caribbean Cruises And Some Other Big Stocks Moving Lower On Monday August 01, 2022 FiscalNote Holdings Inc. (NYSE: NOTE) fell 22.7% to $6.43. FiscalNote closed its earlier-announced agreement to acquire Aicel Technologies. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session July 18, 2022 Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million. Via Benzinga The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives June 28, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For August 15, 2022 August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. Via Benzinga Earnings Scheduled For June 28, 2022 June 28, 2022 Companies Reporting Before The Bell • Jupai Hldgs (NYSE:JP) is projected to report earnings for its first quarter. Via Benzinga Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus June 28, 2022 From Pfizer Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session June 17, 2022 Gainers Travere Therapeutics (NASDAQ:TVTX) stock increased by 16.5% to $28.87 during Friday's after-market session. The market value of their outstanding shares is at $1.8 billion. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 25, 2022 Via Benzinga The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures May 24, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022 May 23, 2022 Via Benzinga 110 Biggest Movers From Friday May 16, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022 April 29, 2022 Upgrades Via Benzinga Stocks That Hit 52-Week Lows On Wednesday April 20, 2022 On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.